Józsi Mihály
MTA-ELTE "Lendület" Complement Research Group, Department of Immunology, Eötvös Loránd University, Budapest, Hungary.
Front Immunol. 2017 May 18;8:571. doi: 10.3389/fimmu.2017.00571. eCollection 2017.
Human-pathogenic microbes possess various means to avoid destruction by our immune system. These include interactions with the host complement system that may facilitate pathogen entry into cells and tissues, expression of molecules that defuse the effector complement components and complexes, and acquisition of host complement inhibitors to downregulate complement activity on the surface of the pathogen. A growing number of pathogenic microorganisms have acquired the ability to bind the complement inhibitor factor H (FH) from body fluids and thus hijack its host protecting function. In addition to FH, binding of FH-related (FHR) proteins was also demonstrated for several microbes. Initial studies assumed that these proteins are complement inhibitors similar to FH. However, recent evidence suggests that FHR proteins may rather enhance complement activation both directly and also by competing with the inhibitor FH for binding to certain ligands and surfaces. This mini review focuses on the role of the main alternative pathway regulator FH in host-pathogen interactions, as well as on the emerging role of the FHR proteins as enhancers of complement activation.
人类致病微生物拥有多种手段来逃避我们免疫系统的破坏。这些手段包括与宿主补体系统相互作用,这可能有助于病原体进入细胞和组织;表达能够化解补体效应成分和复合物的分子;以及获取宿主补体抑制剂以下调病原体表面的补体活性。越来越多的致病微生物已经获得了从体液中结合补体抑制剂因子H(FH)的能力,从而劫持其宿主保护功能。除了FH,还证明了几种微生物能够结合FH相关(FHR)蛋白。最初的研究认为这些蛋白是类似于FH的补体抑制剂。然而,最近的证据表明,FHR蛋白可能反而会直接以及通过与抑制剂FH竞争结合某些配体和表面来增强补体激活。本综述聚焦于主要替代途径调节因子FH在宿主 - 病原体相互作用中的作用,以及FHR蛋白作为补体激活增强剂的新出现的作用。